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RAPID COMMUNICATION
Acute Infection of Chinese Macaques by a CCR5-Tropic
SHIV Carrying a Primary HIV-1 Subtype B’ Envelope
Haibo Wang, PhD,*† Ke Zhuang, PhD,* Li Liu, PhD,† Zhijiao Tang, MD,‡ Juanjie Tang, PhD,*
Po Tien, PhD,* Linqi Zhang, PhD,§k and Zhiwei Chen, PhD, DVM†
Abstract: The increasing prevalence of HIV-1 subtype B in China
and Southeast Asia calls for efforts to develop a relevant animal
model to study viral transmission and pathogenesis. Because there are
significant differences between subtype B HIV-1 and other chimeric
simian/human immunodeficiency viru (SHIVs) in the env gene,
a novel SHIV, designated SHIVB’WHU, was generated by replacing
counterparts of SHIVSF33 with tat/rev/vpu/env genes derived from
a primary, CCR5-tropic, subtype B’ HIV-1 strain of a Chinese patient.
SHIVB’WHU was able to replicate in rhesus peripheral blood
mononuclear cells and used CCR5 as its major coreceptor. Moreover,
after serial passages in Chinese macaques, the in vivo infectivity of
SHIVB’WHU was enhanced, yet no significant sequence changes were
found in viral envelopes, and the virus did not change its CCR5-
tropism. CD4+ T-cell loss, however, was found in the intraepithelial
lymphocytes of small intestines of infected macaques. Our findings
have implications in understanding the early pathogenesis of
SHIVB’WHU in Chinese macaques.
Key Words: acute infection, animal model, Chinese macaques,
SHIV, subtype B’
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INTRODUCTION
Human immunodeficiency virus type one (HIV-1)
epidemic in China is largely driven by several high-risk
factors.1 One of the risk factors is paid blood donation
(PBD), which was initially identified in Henan province,
where many poor farmers were infected through illegal
blood collection practices without adequate screening
and sterilization procedures.2,3 Many of the infections
occurred when contaminated blood cells were transfused
back to donors once the plasma had been removed from the
pooled blood. Over the past years, such activities, which
peaked between 1992 and 1996, have caused hundreds of
thousands of new infections among paid blood donors in
rural areas in Henan and neighboring provinces including
Anhui, Hubei, Hebei, Shaanxi, and Shanxi,2,4 creating the
tragic ‘‘AIDS villages’’5,6 and attracting tremendous public
attention.7,8 Although illegal PBD has been banned by the
Chinese government, the increasing prevalence of HIV-1
subtype B’ through other risk behaviors including un-
protected sexual contacts still calls for efforts to fight
the epidemic.
To fulfill the goal of controlling HIV-1 dissemination
from high-risk groups into general populations,9,10 there is
a need to understand the viral transmission and to develop an
effective preventive means. Because many preventive means
cannot be tested in humans, it is desirable to develop a relevant
animal model. Therefore, a lot of efforts have been put on the
development of the chimeric simian/human immunodeficiency
virus (SHIV).11–13
Most of currently available SHIVs utilize envelope
genes derived from HIV-1 subtype B strains, either from
laboratory-adapted, syncytium-inducing, T-tropic viruses
(HIV-1HXB2 and HIV-1NL43) or from primary, nonsyncytium-
inducing, M-tropic (HIV-1SF162), syncytium-inducing
T-tropic (HIV-1SF33) and dual-tropic (HIV-189.6 and HIV-
1DH12) isolates.
14,15 In addition, a few nonsubtype B SHIVs
were generated for subtype C and E including the
SHIVCHN19 that we previously generated to study the major
HIV-1 epidemic caused by subtype C and CB recombinant
viruses in China.16–18 Till now, however, no SHIV has been
generated based on the envelope of subtype B’ HIV-1,
another major epidemic strain in China and Southeast Asia.
Moreover, it remains unknown whether or not a SHIV
generated from a freshly isolated human HIV-1 would be
pathogenic in vivo during acute phase of infection. Here, we
report the construction and characterization of a new
SHIVB’WHU both in vitro and in vivo.
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MATERIAL AND METHODS
Amplification of HIV-1 tat/rev/vpu/env Genes
The genomic DNAwas extracted from peripheral blood
mononuclear cells (PBMCs) of an HIV-1–infected PBD
(02HNSMX2).
2 The HIV-1 tat/rev/vpu/env fragment was ampli-
fied from genomic DNA by a nested polymerase chain reaction
(PCR) using the EXPAND high-fidelity DNA polymerase
according to the manufacturer’s specifications (Boehringer-
Mannheim, INAU2 ). The outer primer pair is 4759F1 (5#-GTT
TTT CAG AAT CTG CTATAA GAA ATG CC-3#), BU5 (B)
(5#-CTC TAG TTA CCA GAG TCA CAC AAC AGA CGG
GCA CAC AC-3#) and the inner primer pair is VprA
(5#-TGCC GAATTCGCATGC TA TAG A TAG AGG AGA
GCA AGA AAT GGA G -3#) and EnvB (5#-TGCC CTCGAG
CT TAT AGT AAA GCC CTT TCG AGG-3#), where the
introduced stop codons are underlined and the restriction
enzyme sites (EcoRI, SphI, and XhoI) are italicized. Products
from the second-round amplifications were purified from
agarose gels using QIAquick gel extraction kit (Qiagen,
Valencia, CA).
Construction of SHIVB’WHU
The env sequence was subjected to the phylogenetic
analysis as previously described.16 PVP-1 plasmid contains tAU3 he
5#-half SIVmac239 genome from the 5# long terminal repeat,
a generous gift of Dr Paul Luciw. 3# half vpu+-B’WHU plasmid
(3#-p02HNSMX2-B’WHU) contains the 3#-half of SHIVB’WHU
genome. The 3#- p02HNSMX2-B’WHU plasmid was made by
replacing counterparts of SHIVSF33 (a generous gift of Dr
Cecilia Cheng-Mayer) with newly obtained subtype B’
tat/rev/vpu/env genes. To make a replication-competent recom-
binant SHIVB’WHU, linear 5#-PVP-1 and 3#-p02HNSMX2-
B’WHU plasmids were co-transfected into 293T cells using
Effectene Transfection Reagent (Qiagen, Valencia, CA).
Forty-eight hours later, 1 3 107 CEM 3 174-5.25M7 cells
in DMEM media were placed into the 60 mm dishes
containing the transfected 293T cells and supernatant. The
culture supernatants were harvested for p27 measurement and
used to infect macaque PBMCs. Some transfected 293T cells
were also subjected to the cell fusion assay to test the
expression and phenotype of Env as we previously described.16
Genetic Analysis of Amplified HIV-1 Genes
Full-length tat/rev/vpu/env amplicon was cloned into the
expression vector pcDNA-I/Amp (Invitrogen, Carlsbad, CA)
and was subsequently sequenced. The full env sequence was
subjected to phylogenetic analysis.1,2 The phylogenetic tree
was generated using the neighbor-joining method imple-
mented in the ClustalX1.8 program. The tree was plotted
using the TreeView program.19 The SimPlot and BootScan
analysis was used to determine the possible intersubtype
recombination.20
Replication of SHIVB’WHU in Chinese
Macaque PBMCs
Macaque blood was obtained from healthy adult Chinese
rhesus monkeys that were provided by Wuhan University
Laboratory Animal Center. PBMCs were separated from the
whole blood by centrifugation through Ficoll-Paque PLUS
(GE Healthcare, Piscataway, NJ) density gradients. To test the
infectivity of newly generated SHIVB’WHU strain, 1 3 10
7
stimulated macaque PBMCs were infected by cell-free virus
with an equal inoculum (p27 titer: 0.5 ng/mL). The infected
PBMCs were cultured in 10% FBS RPIM-1640 containing
20U IL-2. On day 5, 10 and 15 postinfection, the viral
supernatants were harvested for p27 measurement. The p27
level was measured using a kit purchased from ZeptoMetrx
Corporation (Buffalo, New York, NY).
FACS ANALYSIS
The n AU4umber of peripheral CD4+ and CD8+ lymphocytes
in SHIV-infected animals was determined by fluorescence-
activated cell sorter using fluorochrome-conjugated mono-
clonal antibodies as described previously.16
Inoculation of Chinese Macaques
With SHIVB’WHU
Four juvenile Chinese rhesus macaques were infected
with SHIVB’WHU in this study. A dose of 1.1 mg p27 in
a volume of 15 mL of cell-free viral supernatant was infused
intravenously via the femoral vein into a Chinese macaque
(P1-#0002). For serial passage, 10 mL of heparinized whole
blood and 5 mL of bone marrow collected from the P1-#0002
macaque at 2 weeks postinoculation were inoculated in-
travenously, also via the femoral vein, into another healthy
Chinese macaque (P2-#0296). Subsequent passages for P3
(P3-#1032) and P4 (P4-#1050) animals were carried out in the
same manner as for P2-#0296 animal. Our experimental
protocols were reviewed and approved by the Institutional
Animal Care and Use Committee at the Laboratory Animal
Center in Wuhan University Laboratory Animal Center, where
the experimental animals were housed.
Viral Load Measurement
The level of plasma viremia and viral RNA and proviral
DNA loads in tissues was measured by a quantitative real-time
PCR method as described previously.16,17 A molecular beacon-
based real-time PCR assay was used to quantify the copy
number of SHIVB’WHU in plasma using the ABI 7700 PRISM
spectrofluorometric thermal cycler (Applied Biosystems,
Foster City, CA). The limit of detection for plasma viral load
was approximately 400 RNA copies per mililiter after the
adjustment of the dilution factors.
Immunohistochemistry
Tissue sections from formalin-fixed paraffin-embedded
small intestines (SIs) (jejunum) were stained with a mouse
anti-human CD4 monoclonal antibody (NCL-CD4-1F6;
Novacastra Laboratories, Ltd, London, United Kingdom)
using the DakoCytomation-Labelled Streptavidin-Biotin2
System, Horseradish Peroxidase (LSAB2 System, HRP,
DAKO Corporation, Carpinteria, CA) and AEC Substrate–
Chromogen solution (DAKO Corporation) as previously
described.21,22
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Determination of Coreceptor Usage
The coreceptor usage of the postpassage SHIVB’WHU
was determined by using GHOST CD4 cells expressing each
of the following proteins including CCR1, CCR2b, CCR3,
CCR4, CXCR4, CCR5, CCR8, Bob, Bonzo, and V28.
Viral isolates were used to infect each of the cell types in
duplicate in 96-well plates at a multiplicity of infection of
1.0. After incubation at 37C for 2 hours, the cultures were
washed 3 times with phosphate-buffered saline and
maintained in the culture medium. The cells were photo-
graphed by fluorescent microscopy to detect GFP expression
24–48 hours postinoculation.
RESULTS
Sequence Analysis of SHIVB’WHUenv Gene
To generate a subtype B’ SHIV, we amplified the
tat/rev/vpu/env fragments of HIV-1 subtype B’WHU from the
proviral genome of a patient’s PBMCs (02HNSMX2) by a nested
PCR. Sequencing results indicated that the open-reading
frames of tat/rev/vpu/env genes were complete without any
frame shift. Because viral envelope determines viral genotype
and phenotype,23 a phylogenetic analysis was conducted to
determine the viral genotype as previously described.16 As
depicted in the neighbor-joining tree (F1 Fig. 1), the SHIVB’WHUenv
clustered tightly with subtype B’ strains identified either in
Henan (02HNsmx2, 02HNsc11, and 02HNsq4), Yunnan
(B’YN.RL42) of China or in other Southeast Asian countries
such as Thailand (subtype B’.TH.93TH067) and Myanmar
(subtype B’.MM.99.mSTD101). In contrast, env sequences
from western countries, including those from the United States,
are divergent from subtype B’ virus (Fig. 1).2,24 Furthermore,
the SimPlot and BootScan analysis showed that the env of
SHIVB’WHU is a pure B’ without cross over or recombination
with viruses of other subtypes, including subtype C/B’ viruses
currently circulating in China.1,16 When compared with env
genes of other SHIV strains including SHIV89.6, SHIVSF33,
SHIVSF162, SHIVKU2, SHIV1157ipd3N4, SHIVCHN19, SHIVMJ4, and
SHIVE-CAR (Fig. 1),
18,25 SHIVB’WHUenv is the only unique one
representing the subtype B’ viral cluster. In addition, there were
significant differences between SHIVB’WHU and other SHIVs
especially in variable regions (V1, V2, V3, V4, and V5) based
on the aligned amino acid sequences (See Figure, Supple-
mental Digital Content 1, http://links.lww.com/QAI/A28). The
amino acid similarity between SHIVB’WHU, and each of these
SHIV strains as mentioned above is 82%, 83%, 85%, 83%, 77%,
77%, 73%, and 75%, respectively.
Serial Passages of SHIVB’WHU in
Chinese Macaques
We first determined that SHIVB’WHU used CCR5 as its
coreceptor and was able to replicate in rhesus PBMCs (data
not shown). To enhance the infectivity of SHIVB’WHU, in vivo
serial passage of SHIVB’WHU was performed in 4 naive Chinese
rhesus macaques.16,26 Cell-free SHIVB’WHU supernatant was
inoculated intravenously into a healthy Chinese rhesus monkey
(P1-#0002). Fourteen days after the inoculation, 10 mL of
heparinized blood and 5 mL of bone marrow from this animal
was inoculated intravenously into a second naive animal
(P2-#0296). Such in vivo passage was carried out sequentially
into the third and the fourth naive rhesus monkeys (P3-#1032
and P4-#1050), respectively. Unexpectedly, there was no
detectable viremia in P1-#0002 during the 14 days of infection
( F2Fig. 2). P2 animal (P2-#0296), however, developed productive
infection as indicated by a burst of viremia (106 copies of viral
RNA per mL of plasma) 14 days after the blood-bone marrow
transfusion. Further in vivo passages of SHIVB’WHU have
improved the viral infectivity because the burst of viral
replication was detected earlier on day 12 with viral loads
ranging 106 to 107 copies of viral RNA per milliliter of plasma
(Fig. 2). During these 14 days of acute infection, there was no
significant change in peripheral CD4+ and CD8+ T-cell counts in
all 4 infected Chinese rhesus macaques.
Quantification of Proviral DNA and Viral
RNA in Tissues
Because SHIVB’WHU is a R5-tropic virus, we were
curious to understand viral infection and pathology in the guts
during the acute phase of infections, which has not been
previously studied with any SHIVs before in vivo adaptation.
Therefore, all animals were sacrificed 2 weeks postviral
inoculation. Proviral DNA and viral RNA loads in tissues were
FIGURE 1. Phylogenetic analysis of the full-length env gene of
SHIVB’WHU. SHIVB’WHU is indicated by the arrow. The reference
sequences were obtained from the HIV sequence database in
GenBank. The tree was constructed by using full-length env
nucleotide sequences by a neighbor-joining method as pre-
viously described.1,2 The length of branches is additive and
represents genetic distance between pairs of viruses. The solid
scale bar indicates a genetic distance of 0.02. The reference
SHIV strains are shown in bold.
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determined by a quantitative real-time PCR assay as pre-
viously described.17,27 In this analysis, SI, axillary lymph node
(ALN) and mesenteric lymph node were examined in all
animals (F3 Fig. 3). Interestingly, despite the absence of detect-
able viral RNA in peripheral blood of P1-#0002, there was
significant level of viral RNA load and proviral DNA load in
ALN of this animal (Fig. 3A). In P2-#0296 monkey,
accompanying the burst of viremia on day 14 post transfusion,
proviral DNA and viral RNA were mainly detected in SIs in
addition to low levels in ALN. In P3-#1032 and P4-#1050
monkeys, with the earlier burst of viremia on day 12
postinoculation, the viral RNA load and provial DNA load
were significantly higher in SIs. Moreover, both proviral DNA
and viral RNA load were significantly higher in mesenteric
lymph nodes (Fig. 3B), which belongs to mucosal tissue
compartments. It is possible that the enhanced viral infectivity
is related to the increasing infection of CD4+ T lymphocytes in
mucosal tissue compartments. As for the failure of detectable
viral load in other tissues, we believed that it was probably due
to the limit of our viral load assay because viral genes
were readily detected in all tissue compartments tested by
nested PCR.
Immunohistochemistry Analysis of CD4+
T Cells in SIs
To further determine the pathogenicity of CCR5-tropic
SHIVB’WHU during in vivo passages, the cytopathic effect of
viral infection was investigated in the SIs. We were unable to
analyze the CD4+ T cells using the flow cytometry technique
due to the lack of equipment at our study site. Immunohis-
tochemistry analysis, however, was performed on formalin-
fixed paraffin-embedded SIs to determine the loss of CD4+ T
cells using a mouse anti-human CD4 monoclonal antibody.22
CD4+ T cells were stained red as shown in F4Fig. 4. For each
monkey, we analyzed multiple tissue sections and multiple
fields of each tissue section. Compared with uninfected rhesus
monkeys, the number of CD4+ T cells in SHIVB’WHU-infected
monkeys was significantly reduced especially among the
intraepithelial lymphocytes (IEL) of SIs. CD4+ T cells were
detected among the lamina propria lymphocytes but with
reduced numbers, and in mucosa-associated lymphocyte
aggregates or tissues (Fig. 4).
Unchanged CCR5-Tropism of SHIVB’WHU After
Serial Passage
To determine the viral coreceptor usage, viruses were
reisolated from P2-P4 passaged monkeys. These viral isolates
were used to infect GHOST CD4 cells expressing each of the
coreceptors, including CCR1, CCR2b, CCR3, CCR4,
CXCR4, CCR5, CCR8, Bob, Bonzo, and V28. These isolates
FIGURE 2. Characterization of plasma viral load in infected
animals. The viral load of infected animals was measured using
a real-time PCR assay. The Y axis represents viral RNA copies per
milliliter of plasma. The X axis indicates the time post-
inoculation.
FIGURE 3. The quantification of viral
RNA (top) and proviral DNA (bot-
tom) in different tissues: Axillary LN
(A, D), Mesenteric LN (B, E), and SI
(C, F). Viral RNA copies (GAPDH
copies)21 and proviral DNA copies
(mg DNA)21 were determined by
real-time PCR assays. The error bar
indicates the experimental variation,
whereas the dot line indicates the
cut-off value. Viral env genes were
amplified by nested PCR for se-
quence analysis from all tissue com-
partments as shown here. NC refers
to uninfected negative control.
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infected GHOST CD4 Hu-CCR5 cells but not other cells
(See Figure, Supplemental Digital Content 2,
http://links.lww.com/QAI/A29). with a pattern similar to that
of the parental SHIVB’WHU. Furthermore, there were only low
frequent sporadic amino acid substitutions identified in their
env fragments. These results suggest that, despite in vivo serial
passage, SHIVB’WHU has maintained CCR5 specificity with no
evidence of altered coreceptor utilization.
DISCUSSION
Over the past years, Asia has become the second most
heavily affected continent by HIV/AIDS in the world. Because
Asia has theworld’s largest human population, effectivemeasures
must be implemented to control the increasing prevalence of
HIV-1 infection. To this end, the development of a relevant animal
model to facilitate the testing of various preventive measures
(eg vaccine, microbicide, antivirals) remains necessary. HIV-1
subtypeB’ is amajorHIV-1genotypenot only inChinabut also in
other Southeast Asia countries.2,28 Because there is a significant
amount of sequence variation in env genes of subtype B’ and
western B viruses (See Figure, Supplemental Digital Content
1, http://links.lww.com/QAI/A28). currently available B SHIVs
are not necessarily suitable for studies of subtype B’ viral
transmission and pathogenesis. For example, recent studies
indicated that some subtype B’ HIV-1 strains are less susceptible
to a few potent neutralizing antibodies derived from patients
infected with western B viruses.29 The newly constructed
SHIVB’WHU is therefore particularly useful for studying issues
related to subtype B’ env-mediated infection in a nonhuman
primate model.
The infectivity of SHIVB’WHU was enhanced in Chinese
macaques after in vivo serial passage. Before in vivo passage,
the phenotype and replication kinetics of SHIVB’WHU was
determined by in vitro assays. SHIVB’WHU was found to be
CCR5-tropic similar to its primary parental HIV-1 isolate
(See Figure A, Supplemental Digital Content 3,
http://links.lww.com/QAI/A30). This phenotype is crucial
because it represents the dominant type of sexually transmitted
HIV-1 strains.23,30 Furthermore, SHIVB’WHU was demonstrated
to be replication-competent in PBMCs of 2 randomly selected
Chinese macaques (See Figure B, Supplemental Digital
Content 3, http://links.lww.com/QAI/A30), which warranted
the subsequent in vivo experiments. Although no detectable
viremia was found in peripheral blood of P1-#0002 monkey at
the acute phase of infection, the subsequent increasing viremia
detected in P2-P4 animals suggested that SHIVB’WHU has
adapted to grow in vivo and therefore became infectious in
Chinese macaques (Fig. 2). In general, the observed pattern of
SHIVB’WHU replication in macaques is similar to previous
findings of SHIV infection in a newmonkey host.16 Consistently,
the improved growth kinetics and the broader tissue tropism of
SHIVB’WHU in P2-P4 animals suggested the enhanced viral
infectivity in vivo (Figs. 2, 3). The enhanced infectivity, however,
did not result in altered CCR5-tropism and therefore, unlike
pathogenic X4-tropic and X4R5-tropic SHIV strains which
FIGURE 4. Immunohistochemistry analysis of CD4+ IEL loss in SIs of infected macaques. CD4+ T lymphocytes were detected in SIs of
infected and control macaques with a mouse anti-human CD4 monoclonal antibody at 2 weeks postinfection. CD4+ cells are in red.
The arrows showed the CD4+ IELs. At least 5 tissue sections and multiple fields of each section were analyzed for each monkey.
Original magnifications: 3400 (top panel) and 3200 (bottom panel).
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induce severe CD4+ T-cell loss in the periphery,23,31 no
significant CD4+ lymphocytopenia was found in peripheral
blood of SHIVB’WHU-infected macaques. In addition, although
we see enhanced viral replications in P3 and P4 macaques, we
cannot exclude the possibility that the target cells of P1 and P2
are less susceptible to SHIVB’WHU infection.
The rapid in vivo serial passage improved the infectivity of
SHIVB’WHU probably by improving viral fitness and extending
the involvement of tissue CD4+ T lymphocytes in vivo. Previous
investigators demonstrated that serial passage of SHIV in
macaques resulted in virus with high pathogenecity.18,32,33 The
pathogenicity was often indicated by high viral load, CD4+ T
lymphocytopenia, and even simian AIDS. In this study, we
found that a freshly made (before adaptation in macaques)
CCR5-tropic SHIV was able to deplete CD4+ IELs and to less
extent the CD4+ lamina propria lymphocytes in all 4 macaques
tested. This finding suggested that CD4+ IELs were probably
more susceptible to the acute infection of SHIVB’WHU even
without the overtime adaptation of the virus in vivo. However,
the number of experimental animals is small in our study.
Because similar studies were not conducted for other
CCR5-tropic SHIVs, it remains to be determined whether our
finding is a general phenomenon for viruses of the same
phenotype. Moreover, a more quantitative FACS analysis is
needed to determine the quantitative loss of CD4+ IEL in
SHIVB’WHU-infected animals in future study. Previous studies
indicated that some changes were also detected in the IELs
population during SIV infection,34 it might be critical to
determine the role of IELs in seeding the early transmission and
replication of CCR5-tropic HIV-1. Because the viral tropism was
not changed in P3 and P4 monkeys, it is therefore possible that
the improved infectivity of SHIVB’WHU was not simply due to its
phenotypic changes. It is likely that the early involvement of
CD4+ T lymphocytes in broad tissue compartments also
contributed to the rapid burst of viremia especially in P3 and
P4 animals (Fig. 3). To confirm the improved infectivity of the
virus, 3 additional Chinese macaques were recently inoculated
with SHIVB’WHU derived from the P4 animal. All 3 animals have
become infected as indicated by peak viremia and subsequent
seroconversion. These animals will be used to determine
whether or not SHIVB’WHU would lead to persistent infection
and subsequent simian AIDS in Chinese macaques. In addition,
to build a useful SHIVB’WHU/Chinese macaque model, it would
also be necessary to determine the mucosal transmissibility of
SHIVB’WHU with enhanced infectivity in future studies. Lastly,
because different macaque species may respond to SIVor SHIV
infection differently, future studies should determine the
pathogenicity and disease course of SHIVB’WHU infection in
Indian or pig-tailed macaques.
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